Eli Lilly and Company, a leading global pharmaceutical firm, has opened its new regional headquarters for Turkey, Middle East, Africa, Russia and the CIS (TMEA-CIS) in Dubai Healthcare City.

 

Eli Lilly will manage its operations across more than 70 markets from its new base in Dubai, a Wam report in Khaleej TImes said.

 

Speaking at the opening, Dr. Amin Hussain Al Amiri, Assistant Undersecretary for Medical Practice and License Sector at the UAE Ministry of Health,  said: “The United Arab Emirates hosts 90 per cent of the regional offices of the global pharmaceutical companies. We are very happy with Lilly’s decision and initiative to establish a regional office in Dubai that covers several countries, beyond the Middle East Region”.

 

Nabil Daoud, Vice President and Area Director, TMEA – CIS, Eli Lilly, said: “We chose the UAE as the base for our new regional headquarters because this country and its leadership have made a clear and coordinated commitment to quality healthcare and to create an environment that encourages and supports innovation in medical care and treatment.”.